The new fund ICF Venture Tech II has invested €0.5 million in the biotechnology company Vytrus Biotech, a CataloniaBio & HealthTech member.
The Catalan Finance Institute (ICF) investment is part of a financing round of €1.5 million aimed at boosting the growth of Vytrus: 70% of the remaining round has been obtained through different institutional and minority investors, and the other 30% will be closed in this crowdfunding campaign at Sociosinversores.com.
Vytrus bases its business on a technology of vegetable stem cell culture used to develop, produce and market vegetable active ingredients of high added value used for cosmetic and pharmaceutical applications. Currently, Vytrus solds their products in 20 countries.
Comments